Crit Care Med:机械通气患者的临床结局:早期深度镇静vs 轻度镇静

2018-03-13 吴星 环球医学

2018年3月,发表在《Crit Care Med》的一项系统评价和Meta分析,对机械通气患者,早期接受不同深度镇静对死亡结局的影响进行了考察。

2018年3月,发表在《Crit Care Med》的一项系统评价和Meta分析,对机械通气患者,早期接受不同深度镇静对死亡结局的影响进行了考察。

目的:越来越多的研究数据显示早期深度镇静或会对临床结局产生不利的影响。该项系统评价和Meta分析与世界文献中所描述的一样:明确并量化机械通气开始后48个小时内深度镇静的影响。主要结局为死亡率。次要结局包括住院时长、入住ICU的时长、机械通气时长,以及谵妄和气管切开的频率。

数据出处:对如下的数据资源进行了检索:MEDLINE、EMBASE、Scopus、Cochrane Central Register of Controlled Trials、Database of Abstracts of Reviews and Effects、Cochrane Database of Systematic Reviews databases、ClinicalTrials.gov、会议记录,以及参考文献列表。

研究筛选:纳入随机对照试验和非随机研究。

数据提取:两名研究者对选定的符合纳入标准的研究摘要进行独立筛选。

数据综合:纳入了2012年~2017年间发表的9项研究(4521例患者)。一个随机效应Meta分析模型显示,与深度镇静(27.6%)相比,早期轻度镇静(9.2%)与较低的死亡率相关(比值比RR,0.34 [0.21~0.54])。轻度镇静与较短的机械通气(平均差异,–2.1;95% CI,–3.6~–0.5)和ICU入住天数(平均差异,–3.0 ,95% CI,–5.4~–0.6)相关。轻度镇静组的谵妄频率为28.7%,深度镇静组的谵妄频率为48.5%,比值比为0.50(0.22~1.16)。

结论:正如少数符合条件的存在异质性的随机对照试验和观察性研究的评价显示,机械通气患者接受深度镇静与死亡率和住院时长增加相关。针对急诊部开始和随后入住ICU时早期镇静深度评估的干预值得进一步研究,并可改善结局。

原始出处:

Stephens R, Dettmer MR, Roberts BW,et al. Practice Patterns and Outcomes Associated With Early Sedation Depth in Mechanically Ventilated Patients: A Systematic Review and Meta-Analysis. Crit Care Med. 2018 Mar;46(3):471-479. doi: 10.1097/CCM.0000000000002885.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1843156, encodeId=f4df184315689, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Oct 26 00:12:00 CST 2018, time=2018-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973367, encodeId=332819e33679e, content=<a href='/topic/show?id=b0c46613ed7' target=_blank style='color:#2F92EE;'>#深度镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66137, encryptionId=b0c46613ed7, topicName=深度镇静)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Thu Nov 22 00:12:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608637, encodeId=486b160863e8a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 15 07:12:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296084, encodeId=e98729608434, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Wed Mar 14 07:36:18 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1843156, encodeId=f4df184315689, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Oct 26 00:12:00 CST 2018, time=2018-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973367, encodeId=332819e33679e, content=<a href='/topic/show?id=b0c46613ed7' target=_blank style='color:#2F92EE;'>#深度镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66137, encryptionId=b0c46613ed7, topicName=深度镇静)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Thu Nov 22 00:12:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608637, encodeId=486b160863e8a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 15 07:12:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296084, encodeId=e98729608434, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Wed Mar 14 07:36:18 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1843156, encodeId=f4df184315689, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Oct 26 00:12:00 CST 2018, time=2018-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973367, encodeId=332819e33679e, content=<a href='/topic/show?id=b0c46613ed7' target=_blank style='color:#2F92EE;'>#深度镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66137, encryptionId=b0c46613ed7, topicName=深度镇静)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Thu Nov 22 00:12:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608637, encodeId=486b160863e8a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 15 07:12:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296084, encodeId=e98729608434, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Wed Mar 14 07:36:18 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1843156, encodeId=f4df184315689, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Fri Oct 26 00:12:00 CST 2018, time=2018-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1973367, encodeId=332819e33679e, content=<a href='/topic/show?id=b0c46613ed7' target=_blank style='color:#2F92EE;'>#深度镇静#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66137, encryptionId=b0c46613ed7, topicName=深度镇静)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/lGEyfsKnIkkH93xUPMrUUycLh2XOfJJsphwPsVqDx8somSOepIFy9QE0MVAwDW3AS7V1epJ4tbPL9ADJLicvm8A/132, createdBy=b5132500067, createdName=ms55066533437992, createdTime=Thu Nov 22 00:12:00 CST 2018, time=2018-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608637, encodeId=486b160863e8a, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Mar 15 07:12:00 CST 2018, time=2018-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=296084, encodeId=e98729608434, content=不错耶.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Wed Mar 14 07:36:18 CST 2018, time=2018-03-14, status=1, ipAttribution=)]
    2018-03-14 owlhealth

    不错耶.学习了

    0

相关资讯

Crit care med:机械通气患者早期镇静是否有益?

越来越多的数据表明,早期的深度镇静可能会对临床结果产生一定的负面影响。近期,一项发表在杂志Crit care med上的系统综述和荟萃分析定义和量化了机械通气开始的48小时内深度镇静产生的影响。主要结果是死亡率,次要终点包括住院和ICU的住院时间,机械通气时间,谵妄和气管切开发生的频率。此项检索的数据来源有MEDLINE、EMBASE、Scopus、Cochrane对照试验中心登记册,综述和效果的

Anesth Analg:监测声门下二氧化碳水平以优化机械通气患者气管导管套囊压力:随机对照试验

机械通气的许多并发症与气管插管(ETT)套囊压力不适当有关。 本研究的目的是评估长时间插管患者自动套囊压力闭环控制的有效性,其中声门下出现二氧化碳(CO2)作为泄漏指标。 研究的主要结果是使用CO2泄漏随时间曲线下的面积(AUC)量化的套囊周围渗漏量。

机械通气是抢救危重症病人的一大利器,但其复杂繁多的参数应如何设置?

机械通气是指利用机械装置,通过建立气道口与肺泡间的压力差,改善或维持通气和换气功能,纠正低氧血症和高碳酸血症的一种呼吸支持技术,主要目的是为原发病的治疗争取时间。

JAMA:长期机械通气镇静:右美托咪定优于咪达唑仑和丙泊酚

重症监护病房(ICU)的患者长期使用咪达唑仑或丙泊酚镇静会对患者产生严重的不良影响。右美托咪定是一种ICU镇静常用的α-2激动剂,可缩短机械通气时间,提高病人的舒适度。

Crit care med:无机械通气天数可能会误导临床医生的判断!

急性呼吸窘迫综合征患者常常需要有创机械通气,关于其死亡率和机械通气时间均为临床医生重视的结果。已经有学者提出,无需机械通气的天数概念作为上述两个结果的重要补充指标。近期,一项发表在杂志Crit care med上的研究分析了无需机械通气天数的结果,并提供了一个假想的场景以提醒医生,这样的结果可能会导致对临床误导性的解释。研究者们提出了无机械通气天数的曲线概念,并且通过分析发展,说明了如何根据死亡率

汇聚27家医院 17位呼吸专家 机械通气协作中心联盟在陕成立

为了更好的落实国家医改要求,发挥区域性三甲医院的辐射带动作用,1月20日,由西安医学院第一附属医院与省呼吸病预防与诊治工程研究中心承办的“紧密医联体下重症呼吸诊治建设启动会”成功召开。标志着由该院牵头组建的机械通气协作中心联盟正式成立。该联盟由17位省内呼吸领域的专家组成员,27家医院组成。北京协和医院MICU主任杜斌教授、卫生部中日医院对外交流联络处贾存波处长、东南大学附属中大医院谢剑锋博士、西